Cardiac resynchronization therapy in left ventricular hypertrabeculation/ non-compaction and myopathy

Europace

Volumn 10, Issue 1, 2008, Pages 59-62

  Stöllberger, Claudia ^a   Blazek, Gerhard ^b   Bucher, Elisabeth ^a   Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b HANUSCH HOSPITAL   (Austria)

Author keywords

Biventricular pacemaker; Cardiac resynchronization therapy; Cardiomyopathy; Heart failure; Myopathy

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL ARTICLE; COMORBIDITY; DIASTOLE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENERAL CONDITION IMPROVEMENT; HEART CONTRACTION; HEART FAILURE; HEART VENTRICLE SIZE; HUMAN; LEFT VENTRICULAR HYPERTRABECULATION NONCOMPACTION; MALE; MYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; ADOLESCENT; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HEART VENTRICLE; METHODOLOGY; MIDDLE AGED; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR DISEASES; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40349111195     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum245     Document Type: Article

References (18)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
2. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 2006;21:20-6.
3. Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/ noncompaction. J Am Soc Echocardiogr 2004;17:91-100.
4. Aras D, Tufekcioglu O, Ergun K, Ozeke O, Yildiz A, Topaloglu S et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail 2006;12:726-33.
5. Stöllberger C, Winkler-Dworak M, Blazek G, Finsterer J. Prognosis of left ventricular hypertrabeculation/noncompaction is dependent on cardiac and neuromuscular comorbidity. Int J Cardiol 2006. Published online ahead of print December 21.
6. Stöllberger C, Finsterer J. Left ventricular synchronization by biventricular pacing in Becker muscular dystrophy as assessed by tissue Doppler imaging. Heart Lung 2005;34:317-20.
7. Stöllberger C, Keller H, Finsterer J. Disappearance of left ventricular hypertrabeculation/noncompaction after biventricular pacing. J Cardiac Fail 2007;13:211-4.
8. Stöllberger C, Finsterer J. Calcified noncompaction in mannose-binding leptin deficiency and myopathy. Rev Esp Cardiol 2007;60:655.
9. Kubota S, Nogami A, Sugiyasu A, Kasuya K. Cardiac resynchronization therapy in a patient with isolated noncompaction of the left ventricle and a narrow QRS complex. Heart Rhythm 2006;3:619-20.
10. Stöllberger C, Winkler-Dworak M, Blazek G, Finsterer J. Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication. Int J Cardiol 2007;119:28-32.
11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
12. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
13. Bleeker GB, Bax JJ, Fung JW, van der Wall EE, Zhang Q, Schalij MJ et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 2006;97:260-3.
14. Schoppet M, Maisch B. Alcohol and the heart. Herz 2001;26:345-52.
15. Cappola TP, Harsch MR, Jessup M, Abraham WT, Young JB, Petersen-Stejskal S et al. Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. J Card Fail 2006;12:182-8.
16. Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19.
17. Kajimoto H, Ishigaki K, Okumura K, Tomimatsu H, Nakazawa M, Saito K et al. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 2006;70:991-4.
18. Middlekauff HR. How does cardiac resynchronization therapy improve exercise capacity in chronic heart failure? J Card Fail 2005;11:534-41.